trial · primary record
Cenerimod
Lupus Erythematosus, Systemic
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 470 |
| Primary completion | 2027-09-30 |
| Primary endpoint | Response on Systemic Lupus Erythematosus Responder Index 4 (SRI-4) at Month 12 compared to baseline |
| Registry ID | NCT05648500 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:52.235Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05648500
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cenerimod · compound